Home / Import refusals / AEK-9291931-3/60002/1

FDA Import Refusal AEK-9291931-3/60002/1 — Square Pharmaceuticals PLC

Square Pharmaceuticals PLC — FEI 3003670128

The FDA refused shipment AEK-9291931-3/60002/1 from Square Pharmaceuticals PLC (Bangladesh) on January 30, 2026. The refused product falls under Drugs and Biologics — METFORMIN (ANTI-DIABETIC). Cited charge: 75 This firm has 5 or more other import refusals on record.

Refusal Details

Date
January 30, 2026
Country
Bangladesh
Product Category
Drugs and Biologics
Product Code
61PCE26 METFORMIN (ANTI-DIABETIC)
Charges
75

Recent inspections

  • 1157842 (VAI Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 915484 (NAI Fri Jan 30 2015 00:00:00 GMT+0000 (Coordinated Universal Time))

Other import refusals

  • AEK-9362789-9/20002/1 (Tue Mar 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9362789-9/10002/1 (Tue Mar 03 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7845871-6/20002/1 (Mon Nov 10 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Human Foods)
  • AEK-7455482-3/20002/1 (Fri Aug 22 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-8519285-2/22/1 (Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

FDA data resources